Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Currently, Miltenyi Biotec has more than 4,700 employees in 23 countries.
Empowering discovery. Advancing therapy.
Miltenyi Biotec was founded in 1989 based on the invention of MACS® Technology (MAgnetic Cell Separation). Today our more than 19,000 products play a vital role in paving the way for the medicine of tomorrow. We offer comprehensive solutions from basic research to translation into clinical applications.
Our integrated technologies span a broad range of applications, from cellular research to high-content imaging to commercial-scale manufacturing of cellular therapies.
We are scientists ourselves and share a researchers mindset. We are passionate about unraveling nature’s complexity. This is what drives our research and inspires our products.
Contact
Ruben Beuk Marketing Manager BeNeLux
rubenbe@miltenyi.com
+31 6 282 846 29
